At OmniBRx Biotechnologies, we develop and offer cutting-edge Single-use bioreactor technology to produce biologics, vaccines, Cell & Gene therapy, and other biosimilars. Our proprietary "CellBRx®" single-use bioreactor technology is the first-of-its-kind bioreactor device with complete automation which makes it a most reliable platform for vaccine manufacturing. CellBRx® SUB’s are developed upon the concept of Dynamic bed reactor technology, which ensures nutritional & gaseous homogeneity across the cell carrier bed resulting into ultra high-density cell culture. With linear scalability, our product ranges from 1L to 200L bioreactor volume with a surface area from 0.5 M² to 1500M² (17,647 Roller Bottles). Accumulated USP of CellBRx® System delivers 90% cost savings, 10X scalability, and 6X efficiency. The SeedBRx™ technology becomes the first ever close-circuit fully automated Vialto-Harvest production platform with the integrated seed-train development procedure. The SeedBRx bioreactors provide comprehensive end-to-end process automation, allowing high-density cell growth and recover them efficiently. The MiniBRx™ multi-bioreactors are high throughout perfusion-enabled automated bioreactor system for process development with up to 16 fully-featured Single use 100ml/250ml mini-Scale bioreactors. To create and produce game-changing bioprocessing solutions, OmniBRx is prepared to work with international biopharmaceuticals as a trusted partner. To offer maximum benefits we are ready to serve with Lined up Demo batches with validation support and technical assistance.